Paper32504698
An initial screening strategy based on epidemiologic information in esophageal cancer screening: a prospective evaluation in a community-based cancer screening cohort in rural China.
Chen W and 21 others. Gastrointest Endosc, 2021. Cited by 15 papers, by iCite.
Cite this record
ConductScience Library. An initial screening strategy based on epidemiologic information in esophageal cancer screening: a prospective evaluation in a community-based cancer screening cohort in rural China. Papers, record 32504698. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/32504698
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- An initial screening strategy based on epidemiologic information in esophageal cancer screening: a prospective evaluation in a community-based cancer screening cohort in rural China.
- PubMed
Topics8
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Carcinoma, Squamous Cell | Major topic |
| Esophageal Neoplasms | Major topic |
| Esophageal Squamous Cell Carcinoma | Major topic |
| China | |
| Early Detection of Cancer | |
| Humans | |
| Prospective Studies | |
| Risk Factors |
Source PubMed
Comments and corrections1
PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.
| Kind | PMID | Title | In Papers |
|---|---|---|---|
| Comment in | 33353612 | The use of questionnaire-based risk-stratification tools in screening for esophageal squamous cell carcinoma. | https://conductscience.org/library/papers/33353612 |
Source PubMed
Cited by12
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 15 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42823403 | Global incidence of esophageal cancer by histological and anatomical subtypes. | Nat Commun | 2026 | https://conductscience.org/library/papers/42823403 | PubMed |
| 41654824 | Trend analysis of liver cancer mortality in Chinese residents from 2002 to 2021. | BMC Cancer | 2026 | https://conductscience.org/library/papers/41654824 | PubMed |
| 41408438 | Cohort profile: the National Early Gastrointestinal Cancer Cohort (NEGCC) study in China. | Surg Endosc | 2026 | https://conductscience.org/library/papers/41408438 | PubMed |
| 40647436 | Development and Validation of a Score-Based Model for Estimating Esophageal Squamous Cell Carcinoma and Precancerous Lesions Risk in an Opportunistic Screening Population. | Cancers (Basel) | 2025 | https://conductscience.org/library/papers/40647436 | PubMed |
| 38848004 | Improving esophageal cancer screening across the globe: Translating knowledge into action. | Indian J Gastroenterol | 2024 | https://conductscience.org/library/papers/38848004 | PubMed |
| 38544481 | Reducing the global cancer burden with gastrointestinal screening: China's 30 years practice. | Cancer Biol Med | 2024 | https://conductscience.org/library/papers/38544481 | PubMed |
| 37680952 | Long-term esophageal cancer risk and distinct surveillance intervals after a single endoscopy screening: a multicentre population-based cohort study. | EClinicalMedicine | 2023 | https://conductscience.org/library/papers/37680952 | PubMed |
| 36994213 | Clinical characteristics and changing trajectories of esophageal cancer and gastric cancer in China from 2010 to 2019: An analysis of a hospital-based database of 24,327 patients. | Front Oncol | 2023 | https://conductscience.org/library/papers/36994213 | PubMed |
| 36701154 | Development and Validation of Esophageal Squamous Cell Carcinoma Risk Prediction Models Based on an Endoscopic Screening Program. | JAMA Netw Open | 2023 | https://conductscience.org/library/papers/36701154 | PubMed |
| 36534402 | Long-term Incidence Rates of Esophageal Squamous Cell Carcinoma in Chinese Patients With Low-grade Intraepithelial Neoplasia and Association of Surveillance Endoscopy With Incidence. | JAMA Netw Open | 2022 | https://conductscience.org/library/papers/36534402 | PubMed |
| 34878149 | CtBP2 interacts with TGIF to promote the progression of esophageal squamous cell cancer through the Wnt/β‑catenin pathway. | Oncol Rep | 2022 | https://conductscience.org/library/papers/34878149 | PubMed |
| 34527592 | Development and Validation of an Esophageal Squamous Cell Carcinoma Risk Prediction Model for Rural Chinese: Multicenter Cohort Study. | Front Oncol | 2021 | https://conductscience.org/library/papers/34527592 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/32504698
GET https://conductscience.org/api/papers/v1/32504698/authors?page=2